Background illustration for clinical trials search

Vaccines Clinical Trials

Find clinical trials for vaccines. Search for vaccines clinical trials in different cities and states across the United States.

Filter

Capecitabine in ER+/HER2-negative Breast Cancer

for
ER-positive, HER2-negative Breast Cancer, Breast Cancer Stage I,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07631052

Phase 2, Recruiting

Optimization of Cardiac Imaging in Women With Early-Stage Breast Cancer

for
Breast Cancer With Low to Intermediate HER2 Expression
Location: Rochester NY
Sponsor: University of Rochester

Sex: Female

Age: 18 - 70+

Code: NCT07630402

Recruiting

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Boston MA, East Brunswick NJ, Fairfax VA, Tampa FL,
Sponsor: Cogent Biosciences, Inc.

Sex: All

Age: 18+

Code: NCT07383506

Phase 1, Recruiting

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Brewer ME, Providence RI, West Islip NY, Stamford CT,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT07391774

Phase 3, Recruiting

Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

for
Advanced HR+/HER2- Breast Cancer
Location: New Haven CT, Toronto, Kansas City KS, Dallas TX
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07604571

Phase 1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Adaptability of an Undetectable = Untransmissible Model for HBV

for
Chronic Hepatitis b, Viremia
Location: New York NY
Sponsor: NYU Langone Health

Sex: All

Age: 18 - 65

Code: NCT07449091

Recruiting

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

for
Locally Advanced Cancer, Metastatic Cancer, HER2,
Location: Nashville TN
Sponsor: Vanderbilt-Ingram Cancer Center

Sex: All

Age: 18+

Code: NCT06828588

Early Phase 1, Recruiting

Reduced Elective Nodal and CTV Dose for HPV+ Oropharyngeal Squamous Cell Carcinoma

for
Oropharyngeal Squamous Cell Carcinoma,
Location: Cincinnati OH
Sponsor: Sara Medek

Sex: All

Age: 18+

Code: NCT07497607

Phase 2, Recruiting

Yoga for Black and Brown Women Who Have Experienced Abuse From an Intimate Partner

for
Intimate Partner Violence (IPV), Psychological Well Being,
Location: Akron OH
Sponsor: The University of Akron

Sex: Female

Age: 18+

Code: NCT07546266

Phase 1, Recruiting

Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)

for
Common Warts (Verruca Vulgaris), Common Warts,
Location: Hunt Valley MD, Rockville MD, Saint Augustine FL,
Sponsor: Verrica Pharmaceuticals Inc.

Sex: All

Age: 2+

Code: NCT07457918

Phase 3, Recruiting

Intravesical GEM/DOCE for HR BCG-Unresponsive NMIBC

for
Bladder Cancer, Non-Muscle Invasive Bladder Cancer (NMIBC),
Location: Iowa City IA
Sponsor: Michael A. O'Donnell

Sex: All

Age: 18 - 70+

Code: NCT07322263

Phase 2, Recruiting

Feasibility of HPV Self-Collection Kits for Cervical Cancer Screening

for
Cervical Cancer, HPV Infection
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: Female

Age: 25+

Code: NCT07453459

Recruiting

Window of Opportunity in Preserving Laryngeal Function Trial

for
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M),
Location: Pittsburgh PA
Sponsor: Matthew Spector

Sex: All

Age: 18+

Code: NCT07423078

Phase 2, Recruiting

Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)

for
Breast Cancer, Lung Cancer, Melanoma, Gynecologic Cancer,
Location: Toronto
Sponsor: University Health Network, Toronto

Sex: All

Age: 18+

Code: NCT07524114

Recruiting

ERADICATE: A Phase Ib/II Study of Elacestrant Plus Trastuzumab Deruxtecan in Patients With CDK4/6 Inhibitor and Endocrine-resistant HR+/HER2-low or HER2-ultralow Metastatic Breast Cancer

for
Metastatic Breast Cancer, HER2 Low Breast Carcinoma,
Location: Boston MA
Sponsor: Kristina A. Fanucci

Sex: All

Age: 18+

Code: NCT07198724

Phase 1, Phase 2, Recruiting

Hysteroscopy for the Diagnosis and Treatment of Pregnancy of Unknown Location

for
Pregnancy of Unknown Location
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: Female

Age: 18+

Code: NCT07469605

Recruiting

Dissecting Human Immune Responses to Infection With Influenza or SARS-CoV-2

for
Influenza, SARS-CoV-2 (COVID-19) Infection,
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 18 - 60

Code: NCT06848309

Recruiting

Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer

for
Head and Neck Cancer, HPV
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT07065630

Phase 2, Recruiting

Detecting HPV DNA in Anal and Cervical Cancers

for
Cervical Cancer, Anal Cancer,
Location: Chicago IL
Sponsor: University of Chicago

Sex: All

Age: 18+

Code: NCT04857528

Recruiting

A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast Cancer

for
Breast Cancer, HER2-negative Breast Cancer,
Location: Commack NY, Uniondale NY, Harrison NY, New York NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 50+

Code: NCT07483307

Phase 2, Recruiting

What vaccine clinical trials are studying now

New flu vaccines. Moderna's mFlusiva, approved August 5, 2026 for adults 50 and older, is the first mRNA flu vaccine. In its Phase 3 trial it prevented about 27 percent more flu cases than a standard dose vaccine, with more short term side effects. Flu vaccine studies, including human challenge trials, are listed on our influenza clinical trials page.

Vaccines in pregnancy. Vaccinating a mother so antibodies pass to the baby is one of the most active areas of research. A Phase 3 trial of a group B streptococcus vaccine, a leading cause of serious infection in newborns, is recruiting pregnant participants at 120 US sites.

Pneumococcal and other bacterial vaccines. Next generation vaccines that cover more strains of the bacteria behind pneumonia and meningitis, tested against the vaccines in use today. Two pneumococcal vaccine studies are enrolling healthy adults 18 to 75 who have never had a pneumococcal vaccine.

RSV vaccines. Combination and revaccination studies, covered on our RSV vaccine clinical trials page. Studies of new flu and RSV vaccines for adults 60 and older are enrolling now.

Cancer vaccines. These do not prevent cancer; they teach the immune system to attack a cancer that is already there. Intismeran, made for each patient from up to 34 mutations in their own tumor, met its main goal in a Phase 3 melanoma trial in August 2026 but is not yet approved. Smaller studies test vaccines for HER2 positive breast cancer, liver cancer, and HPV related cancers; see our melanoma and breast cancer pages.

COVID-19. Updated formulas are approved each season; the 2026 to 2027 mRNA formula is approved for adults 65 and older and for people 5 to 64 with a condition that raises their risk. One study is testing a COVID-19 vaccine given during an active infection, for people 12 and older who tested positive within the past 5 days and have a risk factor for severe illness; it measures the immune response and is not a treatment for the current illness. Studies of COVID-19 and long COVID are on our COVID-19 page.

Vaccines for infections that have none yet. There is still no approved vaccine against Epstein-Barr virus, the cause of mono, or against C. difficile, a common hospital infection. A study of an EBV vaccine is enrolling healthy adults 18 to 30, and C. diff vaccine studies are enrolling adults 65 and older who have frequent contact with healthcare but have never had the infection.

Human challenge studies. Healthy adults receive a vaccine or placebo, then a controlled dose of a virus such as influenza, in a monitored setting. They answer in weeks what field trials take seasons to show.

Article preview image

65 or older? Read our guide: Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

Not All Flu Vaccines Work the Same After 65: Which to Choose and When to Get It

How vaccine trials differ from drug trials

Who can participate in vaccine clinical trials?

Do vaccine trial participants get paid?

How to enroll in a vaccine clinical trial